Fecal Therapy for Colitis
- Conditions
- Health Condition 1: K51- Ulcerative colitis
- Registration Number
- CTRI/2021/03/032332
- Lead Sponsor
- Dayanand Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age >15 years
Confirmed Ulcerative Colitis patients who are in clinical remission achieved either with FMT or with pharmacotherapy.
Patients must be on stable medication regimen for at least 6 months prior to enrollment.
Able to give informed consent and/or assent as appropriate
Active disease, endoscopic Mayo score > 1, use of rectal therapies, evidence of active infection (stool positivefor Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacteror E. coli), use of probiotics or antibiotics within four weeks of enrollment, significant cardiopulmonary co-morbidities, changes in dosage or addition of new pharmacotherapy in last 6 months, severe immunodeficiency, pregnancy, lactation and unwillingness to undergo repeated colonoscopies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method